Even though some individuals with excess adiposity might be relatively metabolically healthy compared to others with a similar BMI, they may still be considered at risk for obesity-related primarily non-metabolic complications (e.g., osteoarthritis, gallstones, gastro-oesophageal reflux disease) 3
If you or a loved one experienced gastroparesis, vision loss, or other severe health complications after taking Ozempic, Wegovy, or Rybelsus, you may be eligible to seek compensation
"The main theories include things like hormone disruption and obesity, [and] factors like growth factor and insulin increase the risk of cancer, also, immune system dysregulation." He continued, "The question is, how did these medications fit into that puzzle and reduce these risks?" 4
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally designed for type 2 diabetes management have emerged as one of the most powerful pharmacological tools for sustainable weight reduction